JW (Cayman) Therapeutics Co Ltd JWCTF
$0.20
Last Updated: Jul 10, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
JW (Cayman) Therapeutics Co Ltd. Stock Analysis JWCTF
United States Health Care Micro Cap JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company is headquartered in Shanghai, Shanghai and currently employs 314 full-time employees. The company went IPO on 2020-11-03. The firm has built an integrated platform for product development in cell immunotherapy, as well as a product pipeline covering hematologic malignancies, solid tumors and autoimmune diseases. The Company’s main product, Carteyva, is an autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) cell immunotherapy product independently developed by the Company based on a CAR-T cell process platform of Juno (a Bristol Myers Squibb company). The firm mainly conducts its business in the domestic market.
JW (Cayman) Therapeutics Co Ltd (JWCTF) Chart
Financial Metrics & Statements of JW (Cayman) Therapeutics Co Ltd (JWCTF)
FAQ's for JW (Cayman) Therapeutics Co Ltd (JWCTF)
- As of August 2026, JW (Cayman) Therapeutics Co Ltd JWCTF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes JW (Cayman) Therapeutics Co Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in JW (Cayman) Therapeutics Co Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of JW (Cayman) Therapeutics Co Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of JW (Cayman) Therapeutics Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of JW (Cayman) Therapeutics Co Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for JW (Cayman) Therapeutics Co Ltd (JWCTF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
